Immunosuppressive activity of ascitic fluid from patients with cancer metastatic to the peritoneum.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Cancer Research

• Publication date

  1977-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 139204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro stimulation of murine lymphoid cell cultures by levamisole.

  1975cited by this paper
• Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response

  1975cited by this paper
• An inhibitor of cell proliferation released by cultures of macrophages.

  1974cited by this paper
• Suppression of the mitogenic response to phytohemagglutinin in malignant neoplasia: correlation with clinical stage and therapy.

  1974cited by this paper
• Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer.

  1974cited by this paper
• Rosette-forming lymphocytes in normals and patients with malignant lymphomas.

  1974cited by this paper
• Immunosuppression induced with cell-free fluid of Ehrlich carcinoma ascites and its fractions.

  1973cited by this paper
• Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stage

  1973cited by this paper
• Abrogation of Lymphocyte Trapping by Ascitic Tumours

  1973cited by this paper
• Changes in phytohemagglutinin response due to presence of tumors.

  1973cited by this paper
• Immunosuppression mediated by Ehrlich ascites fluid.

  1973cited by this paper
• Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.

  1973cited by this paper
• Isolation of an immunosuppressive peptide fraction from human plasma.

  1973cited by this paper
• Immune response suppression by an inhibitor in normal and immune mouse serum.

  1972cited by this paper
• The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro.

  1972cited by this paper
• Immunologic and virologic properties of chemically and gamma-irradiation-induced thymic lymphomas in mice.

  1972cited by this paper
• Response of lymphocytes in chronic lymphocytic leukaemia to plant mitogens.

  1972cited by this paper
• Lymphocyte Sensitization in Advanced Malignant Disease: A Study of Serum Lymphocyte Depressive Factor

  1972cited by this paper
• Phytohemagglutinin Unresponsiveness in Mouse Spleen Cells Induced by Methylcholanthrene Sarcomas

  1971cited by this paper
• Serum inhibitors of lymphocyte responses.

  1971cited by this paper
• Inhibition of secondary immune responses by immunoregulatory alphaglobulin.

  1971cited by this paper
• Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma.

  1971cited by this paper
• The immune response to heterologous red cells in mice. V. The effect of cyclophosphamide and cortisone on antigenic competition.

  1970cited by this paper
• Impaired immunologic reactivity and recurrence following cancer surgery

  1970cited by this paper
• Diagnostic procedures for viral and rickettsial infections

  1969cited by this paper
• Transformation of Human Lymphocytes: Inhibition by Homologous Alpha Globulin

  1968cited by this paper
• SELECTIVE INHIBITION OF THE SECONDARY IMMUNE RESPONSE TO MOUSE SKIN ALLOGRAFTS BY CELL-FREE EHRLICH ASCITES CARCINOMA FLUID

  1968cited by this paper
• Dissociation and Inhibition of the Stimulatory Effect of Phytohaemagglutinin on Protein and DNA Synthesis in Human Lymphocyte Cultures

  1967cited by this paper
• Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

  1966cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Ovarian Cancer Ascites Inhibits Transcriptional Activation of NK Cells Partly through CA125

  2022cites this paper
• Partial Purification and Characterization of a Lymphocyte-inhibitory Factor ( s ) in AsciticFluidsfrom OvarianCancer Patients '

  2006cites this paper
• Systemic effects of cancer: role of multiple proteases and their toxic peptide products.

  2005cites this paper
• isolation and Characterization of an Immunosuppressive Acidic Protein from Ascitic Fluids of Cancer Patients 1

  2004cites this paper
• Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients

  2004cites this paper
• Cancer cachexia: Its correlations and causes

  2003cites this paper
• α‐1 acid glycoprotein is an immunosuppressive factor found in ascites from ovarian carcinoma

  1997cites this paper
• Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma.

  1997cites this paper
• Cell-mediated-immunity and immunotherapy in ovarian-cancer (review).

  1995cites this paper
• Ascites levels of haptoglobin in patients with ovarian cancer

  1993cites this paper
• Enhanced immunosuppressive activity associated with metastatic lymphoma cells.

  1993cites this paper
• Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer

  1992cites this paper
• Natural inhibitors of T-cell activation in Hodgkin's disease.

  1991cites this paper
• Ovarian cancer biology.

  1991cites this paper
• Natural inhibitors of T-cell activation in Hodgkin's disease

  1991cites this paper
• The Role of Peptide Growth Factors in Epithelial Ovarian Cancer

  1990cites this paper
• Tumor growth-promoting effect of immunosuppressive substance in mice.

  1989cites this paper
• Role of a SER immune suppressor in immune surveillance.

  1988cites this paper
• Role of spermine in the cytotoxic effects of seminal plasma.

  1987cites this paper
• Biological properties of suppressive E‐receptor factor on lymphokine function

  1987cites this paper
• Shedding of plasma membrane fragments. Neoplastic and developmental importance.

  1986cites this paper
• Immunosuppressive effects of peritoneal fluids from ovarian cancer patients.

  1986cites this paper
• Characterization of an immunosuppressive factor from malignant ascites that resembles a factor induced in vitro by carcinoembryonic antigen.

  1986cites this paper
• Serum-mediated immunosuppression: a possible tumor marker in patients with ovarian carcinoma.

  1985cites this paper
• Need for immunologic stimulators during immunosuppression produced by major cancer surgery.

  1985cites this paper
• E receptor-related immunosuppressive factor in malignant pleural fluid and plasma: molecular mechanism of action on DNA-polymerase-alpha.

  1985cites this paper
• Immunosuppressive Factors in Ascites Fluids From Ovarian Cancer Patients

  1984cites this paper
• Quantitation of serum suppressor factor, related to the erythrocyte receptor of human peripheral blood T lymphocytes as measured by radioimmunoassay.

  1984cites this paper
• Immunologic enhancement of experimental metastasis in the rat

  1984cites this paper
• Immunoregulatory properties and LP-pattern of human ovarian carcinoma ascites and pleural effusions of nonmalignant origin

  1983cites this paper
• Inhibition of interleukin-2-induced proliferation of mouse T cells by normal mouse serum.

  1983cites this paper
• Effect of Immunomodulating Factors Present in Ascitic Fluids and Sera From Cancer Patients on the Responses of Cultured Mononuclear Cells From Normal Subjects

  1982cites this paper
• Immunosuppression related to ascitic fluid in patients with ovarian carcinoma.

  1982cites this paper
• Immunoregulatory activity of cell-free peritoneal washings of mice with Ehrlich ascitic carcinoma

  1982cites this paper
• Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients.

  1981cites this paper
• Nonspecific immunosuppressive factors in malignant ascites: further characterization and possible relationship to erythrocyte receptors of human peripheral T cells.

  1981cites this paper
• Cancer and subversion of host defences.

  1981cites this paper
• Stimulatory effects on various immunologic responses by ascites fluids from patients with metastatic malignancy.

  1981cites this paper
• Malignant ascites associated with advanced gynecologic neoplastic disease.

  1981cites this paper
• Suppression of mitogen- and tumor-cell-induced lymphocyte stimulation by tumor-associated fetal antigens.

  1981cites this paper
• Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid

  1981cites this paper
• A permeability-enhancing factor produced by tumor

  1980cites this paper
• Inhibition of human lymphoblastoid cell line proliferation by ascites fluids from ovarian cancer patients.

  1980cites this paper
• Partial purification and characterization of a lymphocyte-inhibitory factor(s) in ascitic fluids from ovarian cancer patients.

  1980cites this paper
• Suppression of immune anti-tumor lymphocytes by macrophages of advanced tumor bearing rats, across a cell impermeable membrane.

  1979cites this paper
• Spleen cell kinetics in mice bearing the Landschütz ascites tumour.

  1979cites this paper
• An immunostimulatory substance in the ascites fluid of patients with cancer metastatic to peritoneum.

  1979cites this paper
• Factors Influencing Metastasis of Breast Cancer

  1979cites this paper
• Inhibition of macrophage phagocytosis by a human colon tumor cell factor.

  1978cites this paper
• Isolation of a bone-resorptive factor from human cancer ascites fluid.

  1978cites this paper
• Immunosuppressive activity and tissue polypeptide antigen content of human ascitic fluids.

  1978cites this paper
• The biology of cancer invasion and metastasis.

  1978cites this paper
• Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients.

  1977influential citation